Huaren Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Huaren Pharmaceutical Co Ltd cash flow reinvestment rate. Huaren Pharmaceutical Co Ltd (300110) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥7.00 Million (capex CN¥7.00 Million ) from operating cash flow of CN¥86.78 Million. Explore Huaren Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Huaren Pharmaceutical Co Ltd (2007–2025)
Cash flow reinvestment rate of Huaren Pharmaceutical Co Ltd from 2007 to 2025. Historical reinvestment intensity for Huaren Pharmaceutical Co Ltd across 17 annual periods. Explore 300110 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Huaren Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Huaren Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Huaren Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 300110 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥49.34 Million | CN¥390.23 Million | CN¥48.98 Million | ▲ +62.3% |
| 2024 | 0.08x | CN¥25.11 Million | CN¥322.36 Million | CN¥24.69 Million | ▼ -48.4% |
| 2023 | 0.15x | CN¥46.16 Million | CN¥305.60 Million | CN¥45.86 Million | ▼ -82.3% |
| 2022 | 0.85x | CN¥186.14 Million | CN¥217.98 Million | CN¥42.33 Million | ▲ +657.5% |
| 2019 | 0.11x | CN¥34.87 Million | CN¥309.33 Million | CN¥32.02 Million | ▼ -49.3% |
| 2018 | 0.22x | CN¥56.58 Million | CN¥254.32 Million | CN¥45.47 Million | ▼ -55.0% |
| 2017 | 0.49x | CN¥104.47 Million | CN¥211.08 Million | CN¥87.36 Million | ▼ -73.3% |
| 2016 | 1.86x | CN¥337.17 Million | CN¥181.65 Million | CN¥168.95 Million | ▼ -80.0% |
| 2015 | 9.26x | CN¥173.84 Million | CN¥18.77 Million | CN¥156.73 Million | ▲ +133.8% |
| 2014 | 3.96x | CN¥259.80 Million | CN¥65.56 Million | CN¥259.80 Million | ▼ -30.8% |
| 2013 | 5.72x | CN¥227.69 Million | CN¥39.78 Million | CN¥227.69 Million | ▲ +110.5% |
| 2012 | 2.72x | CN¥270.43 Million | CN¥99.44 Million | CN¥270.43 Million | ▼ -30.5% |
| 2011 | 3.91x | CN¥232.83 Million | CN¥59.53 Million | CN¥232.83 Million | ▲ +352.4% |
| 2010 | 0.86x | CN¥67.10 Million | CN¥77.61 Million | CN¥67.10 Million | ▼ -65.7% |
| 2009 | 2.52x | CN¥97.25 Million | CN¥38.63 Million | CN¥97.25 Million | ▲ +10.2% |
| 2008 | 2.29x | CN¥130.82 Million | CN¥57.24 Million | CN¥130.82 Million | ▲ +97.7% |
| 2007 | 1.16x | CN¥8.86 Million | CN¥7.66 Million | CN¥8.86 Million | — |